Observational studyBMC pharmacology & toxicology2020

5-Hydroxytryptamine-3 receptor antagonist and dexamethasone as prophylaxis for chemotherapy-induced nausea and vomiting during moderately emetic chemotherapy for solid tumors: a multicenter, prospective, observational study.

Reiko Matsui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.